COVID-19 pandemic and the great impulse to telemedicine : the basis of the WONCA Europe Statement on Telemedicine at the WHO Europe 70th Regional Meeting September 2020
Telemedicine is the use of telecommunication and information technologies to support the delivery of healthcare at a distance, guaranteeing patients healthcare by facilitating access where barriers exist; the COVID-19 pandemic has attracted worldwide interest in this field.The purpose of this paper is to highlight the main pros and cons of telemedicine, which serve as the basis of the WONCA Europe Statement at the WHO Europe 70th Regional Meeting on 14 September 2020.Pros of telemedicine include virtual healthcare at home, where patients receive support in certain conditions without leaving their houses. During a pandemic, it can be adopted to limit physical human interaction. Unfortunately, it can negatively affect the quality of the doctor-patient relationship, the quality of the physical examination, and the quality of care. Telemedicine requires effective infrastructure and robust investments to be feasible and effective.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Primary health care research & development - 22(2021) vom: 13. Dez., Seite e80 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Petrazzuoli, Ferdinando [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 20.12.2021 Date Revised 08.01.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1017/S1463423621000633 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM334318807 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM334318807 | ||
| 003 | DE-627 | ||
| 005 | 20231225223445.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/S1463423621000633 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1114.xml |
| 035 | |a (DE-627)NLM334318807 | ||
| 035 | |a (NLM)34895388 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Petrazzuoli, Ferdinando |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 pandemic and the great impulse to telemedicine |b the basis of the WONCA Europe Statement on Telemedicine at the WHO Europe 70th Regional Meeting September 2020 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.12.2021 | ||
| 500 | |a Date Revised 08.01.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Telemedicine is the use of telecommunication and information technologies to support the delivery of healthcare at a distance, guaranteeing patients healthcare by facilitating access where barriers exist; the COVID-19 pandemic has attracted worldwide interest in this field.The purpose of this paper is to highlight the main pros and cons of telemedicine, which serve as the basis of the WONCA Europe Statement at the WHO Europe 70th Regional Meeting on 14 September 2020.Pros of telemedicine include virtual healthcare at home, where patients receive support in certain conditions without leaving their houses. During a pandemic, it can be adopted to limit physical human interaction. Unfortunately, it can negatively affect the quality of the doctor-patient relationship, the quality of the physical examination, and the quality of care. Telemedicine requires effective infrastructure and robust investments to be feasible and effective | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a access to care | |
| 650 | 4 | |a rural health | |
| 650 | 4 | |a telemedicine | |
| 700 | 1 | |a Kurpas, Donata |e verfasserin |4 aut | |
| 700 | 1 | |a Vinker, Shlomo |e verfasserin |4 aut | |
| 700 | 1 | |a Sarkisova, Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Eleftheriou, Androulla |e verfasserin |4 aut | |
| 700 | 1 | |a Żakowicz, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Aarendonk, Diederik |e verfasserin |4 aut | |
| 700 | 1 | |a Ungan, Mehmet |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Primary health care research & development |d 2008 |g 22(2021) vom: 13. Dez., Seite e80 |w (DE-627)NLM198028067 |x 1477-1128 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2021 |g day:13 |g month:12 |g pages:e80 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1017/S1463423621000633 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2021 |b 13 |c 12 |h e80 | ||